High density of FOXP3 predicts better prognosis in germinal and non-germinal centre diffuse large B-cell lymphoma.

This study highlights the prognostic impact of FOXP3 and CD68 expression in DLBCL, NOS and in its GCB and non-GCB subtypes. This may help the development of individualized therapy, prognostic prediction and therapy stratification.